Cargando…

Nonlinear relationship between enteric-coated mycophenolate sodium dose and mycophenolic acid exposure in Han kidney transplantation recipients

The aim of the research was to investigate the pharmacokinetics (PK) of enteric-coated mycophenolate sodium (EC-MPS) by quantification of the active metabolite of mycophenolic acid (MPA) after multiple escalating oral doses in Han kidney transplant recipients. A total of 28 Han postoperative kidney...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Jia, Mengmeng, Zuo, Lihua, Li, Na, Luo, Yonggang, Sun, Zhi, Zhang, Xiaojian, Zhu, Zhenfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430868/ https://www.ncbi.nlm.nih.gov/pubmed/28540172 http://dx.doi.org/10.1016/j.apsb.2016.11.003

Ejemplares similares

Pharmacokinetics of Mycophenolate Mofetil and Development of Limited Sampling Strategy in Early Kidney Transplant Recipients
por: Zhang, Jun, et al.
Publicado: (2018)

Orthotopic Heart Transplant Recipient with Enteric-coated Mycophenolate Sodium (Myfortic) Induced Colitis
por: Morris, Craig C., et al.
Publicado: (2020)

Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018)

Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium
por: Jia, Yichen, et al.
Publicado: (2017)

Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
por: Jia, Yichen, et al.
Publicado: (2018)

Comparison of Renal Responses Between Continuous Mycophenolate Mofetil and Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Lupus Nephritis
por: Liao, Yu-Wan, et al.
Publicado: (2022)

Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease
por: Jones, Rachel B., et al.
Publicado: (2014)

Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN)
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2019)

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium
por: Jeon, Kina, et al.
Publicado: (2022)

Cyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation
por: Lee, Su Hyung, et al.
Publicado: (2017)

Improved Gastrointestinal Symptoms and Quality of Life after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus
por: Hwang, Hyeon Seok, et al.
Publicado: (2010)

Celiac-like Enteropathy Associated With Mycophenolate Sodium in Renal Transplant Recipients
por: Filiopoulos, Vassilis, et al.
Publicado: (2018)

Pharmacokinetics and pharmacodynamics profiles of enteric‐coated mycophenolate sodium in female patients with difficult‐to‐treat lupus nephritis
por: Chariyavilaskul, Pajaree, et al.
Publicado: (2022)

The impact of omeprazole on mycophenolate pharmacokinetics in kidney transplant recipients
por: AbdElhalim, Mohamed S., et al.
Publicado: (2020)

Mycophenolic acid AUC in Thai kidney transplant recipients receiving low dose mycophenolate and its association with UGT2B7 polymorphisms
por: Pithukpakorn, Manop, et al.
Publicado: (2014)

Intra-individual variability of mycophenolic acid concentration according to renal function in liver transplant recipients receiving mycophenolate monotherapy
por: Hwang, Shin, et al.
Publicado: (2017)

Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter study
por: Manger, Bernhard, et al.
Publicado: (2015)

Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure
por: Hougardy, Jean-Michel, et al.
Publicado: (2016)

A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial
por: Ranganathan, Dwarakanathan, et al.
Publicado: (2013)

Effect of Mycophenolate Mofetil on Plasma Bioelements in Renal Transplant Recipients
por: Kamińska, Jolanta, et al.
Publicado: (2011)

Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation
por: Ding, Chen-Guang, et al.
Publicado: (2018)

Population Pharmacokinetics of Enteric-Coated Mycophenolate Sodium in Children after Renal Transplantation and Initial Dosage Recommendation Based on Body Surface Area
por: Wang, Guangfei, et al.
Publicado: (2022)

Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients
por: Jung, Hee-Yeon, et al.
Publicado: (2020)

A multicentre, randomised controlled study of enteric-coated mycophenolate sodium for the treatment of relapsed or resistant proliferative lupus nephritis: an Asian experience
por: Anutrakulchai, Sirirat, et al.
Publicado: (2016)

Three-Year Outcomes in Kidney Transplant Patients Randomized to Steroid-Free Immunosuppression or Steroid Withdrawal, with Enteric-Coated Mycophenolate Sodium and Cyclosporine: The Infinity Study
por: Thierry, A., et al.
Publicado: (2014)

Mycophenolate-mofetil/mycophenolic-acid: COVID-19: 4 case reports
Publicado: (2021)

Exposure to Mycophenolate and Fatherhood
por: Midtvedt, Karsten, et al.
Publicado: (2017)

Pharmacokinetics of Mycophenolic Acid after Intravenous Administration of Mycophenolate Mofetil to Healthy Cats
por: Slovak, J.E., et al.
Publicado: (2017)

Association of mycophenolic acid dose with efficacy and safety events in kidney transplant patients receiving tacrolimus: an analysis of the Mycophenolic acid Observational REnal transplant registry
por: Doria, Cataldo, et al.
Publicado: (2012)

Limited Sampling Strategy for Estimation of Mycophenolic Acid Exposure in Adult Chinese Heart Transplant Recipients
por: Xiang, Hongping, et al.
Publicado: (2021)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

A multicenter experience with generic mycophenolate mofetil conversion in stable liver transplant recipients
por: Kim, Jong Man, et al.
Publicado: (2014)

Severe Mycophenolate Intoxication in a Solid Organ Transplant Recipient—No Intervention Actually Needed
por: Åsberg, Anders, et al.
Publicado: (2020)

Optimizing Mycophenolic Acid Exposure in Kidney Transplant Recipients: Time for Target Concentration Intervention
por: Metz, David K., et al.
Publicado: (2014)

Mycophenolate mofetil increases the risk of diarrhea in allogeneic hematopoietic stem cell transplantation recipients
por: Lin, Liangmo, et al.
Publicado: (2023)

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Impact of Sirolimus versus Mycophenolate Mofetil on Kidney Function after Calcineurin Inhibitor Dose Reduction in Liver Transplant Recipients
por: Chiang, Heng-Yi, et al.
Publicado: (2023)

Mycophenolic Derivatives from Eupenicilliumparvum
por: Habib, Eman, et al.
Publicado: (2008)

Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation
por: Sobiak, Joanna, et al.
Publicado: (2015)

Mycophenolate sodium/prednisolone/tacrolimus: COVID-19 infection: case report
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_go8jghf8rd9igmbvud7c91djc7